Corporate Social Responsibility in Eastern Europe

The intervention brought about by the Gardasil vaccine is to cut down the prevalence of the HPV, thereby cutting down on the rate of the HPV related complications. This vaccine, as indicated, is intended to be used on females who are still young before they reach puberty. However, as also noted it can be used on older women of up to 26 years old. This intervention can also be used in the case of women who test positive during a pap smear or for the HPV virus. It should be noted, though, that the shot is a vaccine and not a cure for the virus.

Following this train of thought, everyone at risk of the infection, especially those who are in or just about to attain the age of sexual activity, should take the vaccine (Merck). The reasons why young women should take are almost a no-brainer. The first reason one should take the shot is to reduce the chances of getting the HPV virus, and thus drastically reduce the chances of developing cervical cancer. The other reason has to do with traditional wisdom: a stitch in time saves nine. The vaccine gives the vaccinated individual fewer problems related to health costs in future.

It also relieves the system of the burden of expensive health care expenses that would be as a result of HPV. By reducing the prevalence, the government is able to make cost savings due to the cost effective nature of the vaccination exercise, as seen in Canada (Morris and Nguyen, 2008). The overall result is that it gives the vaccinated a greater chance of living a healthier life and longer. As the world waits for the cures of cancer to become readily available without the many side effects currently experienced, a vaccine will have to do.

The many gains that are seen from the shot, however, have been brought into doubt due to the claim of side effects and even deaths. The supporters of the vaccine cite that after the shot, side effects are common in the young women. These include pain and skin irritation on the injection spot, mild fever, dizziness and a feeling of exhaustion. In extreme cases there may be fainting recorded. The CDC recognizes these after-effects as normal and expected. They are considered temporary and not harmful in the long run. The benefits to be accrued due to enduring the temporal discomfort are worth it.

However, there is a criterion as to who can take the shot and who cannot. It is highly recommended that one candidly explains to the administering doctor their health status, whether they are pregnant and whether they have taken any other vaccine within the given period. Once these measures are taken, the vaccine should be safe and effective (Merck; drugs. com). However, there is another school of thought that thinks otherwise. A report in the Illinois Review stated that there were three deaths related to the Gardasil vaccine.

They died after receiving the shots from complications arising thereafter. There were other cases listed with complications that resulted from the shot. These include paralysis and even the Guillian-Barre Syndrome (GBS). This is a paralysis disease caused by an infection of the nervous system. Other effects cited include Bells Palsy and seizures. This has caused a widespread panic related to the vaccination. One mother has posted her case, in a bid to dissuade other mothers and parents from taking their daughters for the shot.

She claims that her daughter had developed GBS as a result of the vaccine. Her daughter became depressed due to the numerous therapy sessions and loss of mobility that she experienced as a result. This claim is not isolated and there are quite a few claims of the same nature claiming a side effect due to the shot. No wonder there is opposition to the lobbying of mandatory vaccination for young girls. Worried mothers have categorically stated that they will not take their daughters for the vaccine.

Others still are debating on the morality of forcing their daughters to take the shot if it becomes a mandatory vaccine (Stanek, 2007; Nelson, 2008). The medical community has joined in on the debate as to whether the vaccine is viable or not. There are some quarters that state that the producing company over-stretched in its assessment of the effectiveness of the drug. They also state that the figures brought forward by Judicial Watch might not be accurate. They suggest that there may be more cases as not all cases and complications related to the vaccine were reported.

However, Merck, CDC and FDC refute these claims. In fact they state that the claims of side effects and deaths occurring claiming to have resulted from the vaccine cannot be authoritatively proved. The experts within these organizations have continuously trashed these claims terming them as speculative. They advocate for the use of the drug, with Merck lobbying it to be made compulsory for young girls. However, there is hope for the truth as the CDC has promised to study the claims and come up with a report establishing whether there is a link to these complications and the vaccine or not.

These claims and counter claims result in a confusing environment for parents faced with the decision of whether or not to permit their daughters to get the shot and thus do not assist very much in the fight against HPV and cervical cancer (Brudelin, 2008). The debate on the effectiveness of the virus is one that has great implications and interests for everyone. Its implications stretch from health to finance. They touch the lives our sisters, mothers, aunts and other important women in our lives.

Therefore the question as to whether the vaccine is merely a cash cow for Merck, or whether it actually works should be seriously addressed. The debate is one I consider very healthy as it will cause a critical look into how this problem can be solved. Reference Cairo Evelyn. Cervical Cancer. 1998. Sourced 8 April 2009 http://www. public. asu. edu/~squiroga/cairo. HTM CDC HPV and Men. 2008 Sourced 8 April 2009 http://www. cdc. gov/STD/HPV/STDFact-HPV-and-men. htm CDC, gynecologic cancer. Cervical cancer statistics 2008. Sourced 8 April 2009 http://www. cdc. gov/cancer/cervical/statistics/